drugset / Trial / NCT01180413
Intensive Vasodilator Therapy in Patients With Essential Hypertension
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether add-on of intensive vasodilator therapy can improve the coronary perfusion and reduce the total peripheral resistance in patients with ongoing treatment for essential hypertension.
Timeline
- Start
- 2010-12
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Lercanidipine | Small molecule | 20 mg | — |
| Subject | Losartan | Other / unclassified | 100 mg | — |
| Subject | Ramipril | Small molecule | 10 mg | — |